Richard Gaynor

Insider Reports History

Entity
Individual
Location
C/O Neon Therapeutics, 40 Erie Street, Suite 110, Cambridge, Massachusetts
Signature
/s/ Shantale Greenson, attorney-in-fact for Richard Gaynor
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard Gaynor:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zai Lab Ltd Director American Depositary Shares 49.1K $1.05M $21.33 Jun 18, 2024 Direct
Alkermes plc. Director Ordinary Shares 25K $602K $24.10 Jun 29, 2024 Direct
Alkermes plc. Director Non Qualified Stock Option (Right to Buy) 17.5K $537K $30.72 May 31, 2024 Direct
INFINITY PHARMACEUTICALS, INC. Director Stock Option(right to buy) 45K Jun 16, 2022 Direct
Alkermes plc. Director Restricted Stock Unit Award 0 Jun 29, 2024 Direct

Insider Reports Filed by Richard Gaynor

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALKS Alkermes plc. Jun 29, 2024 3 -$35.3K 4 Jul 1, 2024 Director
ZLAB Zai Lab Ltd Jun 18, 2024 1 $0 4 Jun 20, 2024 Director
ALKS Alkermes plc. May 31, 2024 10 $61.4K 4 Jun 4, 2024 Director
ALKS Alkermes plc. Jul 7, 2023 3 -$42.7K 4 Jul 10, 2023 Director
ALKS Alkermes plc. Jun 29, 2023 2 $0 4 Jun 30, 2023 Director
ZLAB Zai Lab Ltd Jun 29, 2023 1 $500K 4 Jun 30, 2023 Director
ALKS Alkermes plc. Jul 7, 2022 2 $0 4 Jul 8, 2022 Director
INFI INFINITY PHARMACEUTICALS, INC. Jun 16, 2022 1 $0 4 Jun 16, 2022 Director
ALKS Alkermes plc. Jun 14, 2022 3 -$18.9K 4 Jun 16, 2022 Director
ALKS Alkermes plc. Dec 2, 2021 3 -$29.6K 4 Dec 3, 2021 Director
ZLAB Zai Lab Ltd Nov 19, 2021 1 $0 4 Nov 22, 2021 Director
ZLAB Zai Lab Ltd Nov 19, 2021 0 $0 3 Nov 22, 2021 Director
ALKS Alkermes plc. Jun 14, 2021 2 $0 4 Jun 16, 2021 Director
INFI INFINITY PHARMACEUTICALS, INC. Jun 10, 2021 1 $0 4 Jun 11, 2021 Director
ALKS Alkermes plc. May 20, 2021 3 -$30.8K 4 May 21, 2021 Director